Search Results - "Cesaro, Samuele"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Functional Characterization of a Spectrum of Genetic Variants in a Family with Succinic Semialdehyde Dehydrogenase Deficiency by Didiasova, Miroslava, Cesaro, Samuele, Feldhoff, Simon, Bettin, Ilaria, Tiegel, Nana, Füssgen, Vera, Bertoldi, Mariarita, Tikkanen, Ritva

    “…Succinic semialdehyde dehydrogenase (SSADH) is a mitochondrial enzyme involved in the catabolism of the neurotransmitter γ-amino butyric acid. Pathogenic…”
    Get full text
    Journal Article
  2. 2

    Conformational Stabilization of Gp41-Mimetic Miniproteins Opens Up New Ways of Inhibiting HIV-1 Fusion by Cano-Muñoz, Mario, Lucas, Julie, Lin, Li-Yun, Cesaro, Samuele, Moog, Christiane, Conejero-Lara, Francisco

    “…Inhibition of the HIV-1 fusion process constitutes a promising strategy to neutralize the virus at an early stage before it enters the cell. In this process,…”
    Get full text
    Journal Article
  3. 3

    Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity by Cano-Muñoz, Mario, Cesaro, Samuele, Morel, Bertrand, Lucas, Julie, Moog, Christiane, Conejero-Lara, Francisco

    Published in Biomolecules (Basel, Switzerland) (12-04-2021)
    “…A promising strategy to neutralize HIV-1 is to target the gp41 spike subunit to block membrane fusion with the cell. We previously designed a series of…”
    Get full text
    Journal Article
  4. 4

    Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol by Palazzi, Luana, Leri, Manuela, Cesaro, Samuele, Stefani, Massimo, Bucciantini, Monica, Polverino de Laureto, Patrizia

    Published in Biochemical pharmacology (01-03-2020)
    “…[Display omitted] Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease in the elderly people. To date, drugs able to reverse the…”
    Get full text
    Journal Article
  5. 5